Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7.
3
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
在 III 期随机试验中比较 III/IV 期卵巢癌、输卵管癌和腹膜癌的初次肿瘤细胞减灭术和新辅助化疗的生存情况。